Study to Assess Epidural Resiniferatoxin for the Treatment of Intractable Pain Associated With Advanced Cancer
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT05067257 |
|
Recruitment Status :
Suspended
(Sorrento Therapeutics filed for chapter 11 bankruptcy.)
First Posted : October 5, 2021
Last Update Posted : April 28, 2023
|
Sponsor:
Sorrento Therapeutics, Inc.
Information provided by (Responsible Party):
Sorrento Therapeutics, Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Suspended |
|---|---|
| Estimated Primary Completion Date : | June 2024 |
| Estimated Study Completion Date : | December 2024 |